The compounds have a high capacity to bind serum albumin, exhibit the ability to inhibit the activities of α-amylase and intracellular PTPs, and furthermore, improve the phosphorylation of the insulin receptor in the human hepatoma (HepG2) cell line. Here, ALB is linked to hepatocellular carcinoma.